Abstract
Huge advances have been made in cancer treatments over recent decades; however, significant disparities still exist in the developed world on the basis of race, socioeconomic status, education level, geographical location, and immigration status and in the United States, insurance status. Cancer disparities persist in the continuum of cancer care from risk factors, screening, diagnosis, treatment, survivorship, and end-of-life care. The causes of disparities are complex and multifactorial. The MASCC (Multinational Association of Supportive Care in Cancer) Education Study Group would like to propose a framework of cancer disparities from a social perspective utilizing “social determinants of health” as delineated by the World Health Organization and highlight an unmet need for research and policy innovations to address cancer disparities in developed world.
Avoid common mistakes on your manuscript.
Introduction
Huge advances have been made in cancer treatments over recent decades; however, significant disparities still exist in the developed world on the basis of race, socioeconomic status, education level, geographical, location and immigration status and in the United States, insurance status [1–6]. While there is no single definition to describe a developed country for the purpose of this article, we are including in developed world, countries with very high United Nations Human Development Index (HDI) [ 7]. HDI takes in to account transformation of income in educational and health opportunities and therefore in to higher level of human development. Cancer disparities continue to persist in the developed world through the continuum of cancer care from risk factors, screening, diagnosis, treatment, survivorship, and end-of-life care [8–10].
In the USA, African Americans experience higher rates of cancer overall and higher mortality from cancer [2]. Certain cancers have higher incidences in particular communities; for example, African Americans in the United States suffer higher risk of prostate cancer and are more likely to die of this disease. Latina women in the United States experience higher rates of cervical cancer. Similarly, Aborigines in Australia continue to experience higher rates of cancer deaths than non-Indigenous populations; for example, cancer of trachea, bronchus, and lungs is 24.5 % higher in the Indigenous population [11]. Minorities in developed countries have poor access to health care, undergo cancer screening at much lower rates, and have higher mortality from cancer [12].
Cancer disparities: a complex challenge
The causes of disparities are complex and multifactorial. They exist within and outside the medical systems in society. There are disparities in risk factors, economic and educational opportunities, and access to health care in different populations within a developed country [1, 5, 13]. There are significant differences within a country and significant differences between different countries in the developed world [4, 14, 15]. Ethnic minorities are over-represented within incarcerated populations [1, 16]. The economic and social disadvantages that underserved patients experience translates into worse cancer-related outcomes [17]. Underserved patients may have low health literacy, which is also associated with worse cancer outcomes [18].
Several ways exist to study cancer disparities. The MASCC (Multinational Association of Supportive Care in Cancer) Education Study Group would like to propose a framework of cancer disparities from a social perspective utilizing “social determinants of health” as delineated by World Health Organization. This model can be used to identify cancer disparities from risk factors, screening, diagnosis, treatment, and end-of-life care. These models represent variables that interact and modify each other. Individual factors such as age, sex, race, and biological characteristics are not modifiable; however, it is possible to mitigate negative experience associated with these characteristics. These characteristics form the individual and social basis of disparities. Older adults may suffer worse outcomes than younger patients by receiving a different treatment. Race/ethnicity is associated with negative experiences of discrimination and segregation of minorities. This may influence individual behaviors and risk factors from early childhood leading to disparities in the incidence and outcomes from cancer and other chronic diseases. Smoking rates are higher in racial and ethnic minorities and with lower education levels. Peer networks, parental smoking, and lack of support for ceasing smoking in immediate neighborhoods influence smoking rates. Minorities often live in poor neighborhoods with cramped living quarters, homelessness, and poor access to health care with few educational and economic opportunities. Lower education status has been associated with higher rates of smoking and higher rates of obesity. Recent migrants particularly from conflict areas of the world and undocumented migrants often live in poor neighborhoods and work in unregulated industries where they may be underpaid and experience unhealthy working conditions [19]. Minorities may have language discordance, different cultural beliefs than health care providers that may lead to dissatisfaction, and poor adherence with established care. Research studies tend to have smaller representation from minorities and underserved patients [9]. Treatment guidelines for cancer screening and treatment, which are based on these studies, may have limited application to underserved population.
The social and economic impact of cancer disparities
Disparities contribute to higher rates of cancer deaths in minorities. In the United States, education attainment between lowest (<12 years) and highest education levels (>12 years) approximately doubles the risk of cancer mortality [ 2, 20]. Health-related expenses increase the chances of descent into extreme poverty for already impoverished individuals. Minorities and vulnerable patients present at advanced stage of cancer with less chances of cure and higher risk of mortality [4]. Vulnerable patients are also less like to receive survivorship care, which decreases the chances of receiving appropriate care at time of recurrence and management of early and long-term effects of cancer and cancer treatments. This patient population is also less likely to receive end-of-life care increasing pain and suffering at the end of life [10]. The elimination of known risk factors and improving health can decrease the incidence of cancer. A higher uptake of screening can shift the cancer burden to an earlier stage resulting in more cures and lower disease burden. A higher access to pain medication and end of life can reduce pain and suffering associated with cancer (Fig. 1).
Next steps
Elimination of cancer disparities will require multilevel interventions. On an individual level, promoting health by influencing health behaviors and improving access to health information may be an important intervention. Harnessing different information resources such as culturally appropriate written materials, audio/video materials, and promoting individual health by increasing the awareness at a community level and by recruiting community leaders as part of an educational intervention may make such initiatives more effective or likely to succeed [21]. A peer support initiative where volunteer peer supporters are utilized to influence health behaviors may be more effective than fliers, books and handouts. Recognizing the strength of community may be useful, such as barbershop initiative for African American patients with hypertension [22].
At medical system levels, all clinicians should be trained to recognize disparities and be aware of the biases that may hinder the patient-provider relationship and communication. Appropriate treatment should be available to all patients irrespective of their social or economic status. Medical researchers should identify not only causes of disparities but also test strategies to mitigate them. Inclusion of minorities in research studies should be prioritized as a requirement in research grants. Increasingly, in this global world, clinical trials that do not include the minorities may have limited applicability. This may require overcoming distrust, which minorities have with health systems, particularly with medical research. A concerted effort should be made to increase the number of minorities as care providers, researchers, and leaders in medical systems. This will enrich our organizations with diversity of experiences and perspectives. While health policies can be a significant intervention to reduce health care disparities, it is social and economic policy that can have the most far-reaching consequences on reducing disparities. The lessons learned in testing these interventions can lead to significant reductions in cancer deaths in developed countries and can be applied to the developing world.
References
Duffy S, Richards M, Selby P, Lawler M (2013) Addressing cancer disparities in Europe: a multifaceted problem that requires interdisciplinary solutions. Oncologist 18(12):e29–e30
Albano JD, Ward E, Jemal A, et al. (2007) Cancer mortality in the United States by education level and race. J Natl Cancer Inst 99(18):1384–1394
Aizer AA, Wilhite TJ, Chen MH, et al. (2014) Lack of reduction in racial disparities in cancer-specific mortality over a 20-year period. Cancer 120(10):1532–1539
Byers TE, Wolf HJ, Bauer KR, et al. (2008) The impact of socioeconomic status on survival after cancer in the United States: findings from the National Program of Cancer Registries Patterns of Care study. Cancer 113(3):582–591
Chong A, Roder D (2010) Exploring differences in survival from cancer among Indigenous and non-Indigenous australians: Implications for health service delivery and research. Asian Pac J Cancer Prev 11(4):953–961
Zeng C, Wen W, Morgans AK, Pao W, Shu XO, Zheng W (2015) Disparities by race, age, and sex in the improvement of survival for major cancers: results from the National Cancer Institute Surveillance, Epidemiology, and End Results (SEER) program in the United States, 1990 to 2010. JAMA Oncol 1(1):88–96
United Nations Development Program 2015 Human Development Report 2015: Work for Human Development Http://Hdr.undp.org/en/composite/HDI.
Fiscella K, Franks P, Meldrum S (2004) Estimating racial/ethnic disparity in mammography rates: It all depends on how you ask the question. Prev Med 39(2):399–403
Mullins CD, Blatt L, Gbarayor CM, Yang HW, Baquet C (2005) Health disparities: A barrier to high-quality care. Am J Health Syst Pharm 62(18):1873–1882
Abdollah F, Sammon JD, Majumder K, et al. (2015) Racial disparities in end-of-life care among patients with prostate cancer: a population-based study. J Natl Compr Cancer Netw 13(9):1131–1138
Australian Institute of Health and Welfare (2011) Cancer in Australia: Actual incidence and mortality data from 1982 to 2007 and projections to 2010. Asia Pac J Clin Oncol 7(4):325–338
Cunningham J, Rumbold AR, Zhang X, Condon JR (2008) Incidence, aetiology, and outcomes of cancer in Indigenous peoples in Australia. Lancet Oncol 9(6):585–595
Patel MI, Schupp CW, Gomez SL, Chang ET, Wakelee HA (2013) How do social factors explain outcomes in non-small-cell lung cancer among Hispanics in california? explaining the Hispanic paradox. J Clin Oncol 31(28):3572–3578
Survival of cancer patients in Europe: The EUROCARE-2 study. IARC Sci Publ. 1999;(151)(151):1–572.
Abdel-Rahman M, Stockton D, Rachet B, Hakulinen T, Coleman MP (2009) What if cancer survival in Britain were the same as in Europe: How many deaths are avoidable? Br J Cancer 101(Suppl 2):S115–S124
Dumont DM, Allen SA, Brockmann BW, Alexander NE, Rich JD (2013) Incarceration, community health, and racial disparities. J Health Care Poor Underserved 24(1):78–88
Flores YN, Davidson PL, Nakazono TT, Carreon DC, Mojica CM, Bastani R. Neighborhood socio-economic disadvantage and race/ethnicity as predictors of breast cancer stage at diagnosis. BMC Public Health. 2013;13:1061–2458-13-1061.
Busch EL, Martin C, DeWalt DA, Sandler RS (2015) Functional health literacy, chemotherapy decisions, and outcomes among a colorectal cancer cohort. Cancer Control 22(1):95–101
Shariff-Marco S, Yang J, John EM, et al. (2014) Impact of neighborhood and individual socioeconomic status on survival after breast cancer varies by race/ethnicity: The neighborhood and breast cancer study. Cancer Epidemiol Biomark Prev 23(5):793–811
Polite BN (2015) States as the laboratory for democracy: Is anybody paying attention, and does anybody care? J Clin Oncol 33(8):815–816
Braun KL, Tsark J, Santos LA, Abrigo L (2003) Native Hawaiian Cancer Awareness Research and Training Network. ‘Imi hale—the Native Hawaiian cancer awareness, research, and training network: second-year status report. Asian Am Pac Isl J Health 10(1):4–16
Victor RG, Ravenell JE, Freeman A, et al. (2011) Effectiveness of a barber-based intervention for improving hypertension control in black men: the BARBER-1 study: a cluster randomized trial. Arch Intern Med 171(4):342–350
Acknowledgments
The authors have no financial relationship pertaining to this manuscript. The authors have made significant contribution to preparation and have seen and approved the final version of manuscript.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors declare that they have no conflicts of interest.
Additional information
On behalf of MASCC Education Study group
Rights and permissions
About this article
Cite this article
Dixit, N., Crawford, G.B., Lemonde, M. et al. Left behind: cancer disparities in the developed world. Support Care Cancer 24, 3261–3264 (2016). https://doi.org/10.1007/s00520-016-3192-4
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00520-016-3192-4